50 Best Peptides
Designed to Feel
Bestseller by Peter Burchardt
Designed to Feel
Your anxiety, jealousy, and anger aren't broken — they're ancient software running in a world they weren't built for. This book is the missing manual.
“The most eye-opening book on emotions I've ever read.”
Get It on Amazon →Available in paperback & Kindle
Research

How Much Weight Can You Lose on Semaglutide?

By 50 Best Peptides Editorial TeamAugust 15, 202610 min read
Share:

How Much Weight Can You Lose on Semaglutide?

In clinical trials, people taking semaglutide 2.4mg (Wegovy) lost an average of 15-17% of their body weight over 68 weeks. For a 250-pound person, that translates to roughly 37-42 pounds. About one-third of participants lost more than 20% of their body weight, and some individuals lost 25% or more. Real-world results tend to be somewhat lower than clinical trial outcomes, with most patients losing 10-15% of their body weight, which is still clinically significant and far exceeds results from most other weight loss medications.

Clinical Trial Evidence: The STEP Program

The most comprehensive data on semaglutide weight loss comes from the STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program, which included multiple large-scale studies with thousands of participants.

STEP 1: The Landmark Study

STEP 1 enrolled 1,961 adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition. All participants received lifestyle counseling, and were randomized to either semaglutide 2.4mg or placebo. After 68 weeks, the semaglutide group lost an average of 14.9% of their body weight, compared to 2.4% in the placebo group.

  • Average weight loss: 14.9% of body weight (approximately 33.7 lbs or 15.3 kg)
  • Participants losing 10%+: 69.1% of semaglutide users vs. 12.0% on placebo
  • Participants losing 15%+: 50.5% of semaglutide users vs. 4.9% on placebo
  • Participants losing 20%+: 32.0% of semaglutide users vs. 1.7% on placebo

STEP 2: In People with Type 2 Diabetes

People with type 2 diabetes typically lose less weight on GLP-1 medications, and STEP 2 confirmed this trend. Participants with diabetes lost an average of 9.6% of their body weight on semaglutide 2.4mg over 68 weeks, compared to 3.4% on placebo. While lower than STEP 1, this still represents significant and clinically meaningful weight loss.

STEP 3: With Intensive Behavioral Therapy

When semaglutide was combined with intensive behavioral therapy including a low-calorie diet for the first 8 weeks, participants lost an average of 16.0% of their body weight. This suggests that combining medication with strong lifestyle modifications can enhance results.

STEP 5: Two-Year Data

STEP 5 provided the longest follow-up, showing that weight loss was maintained over 104 weeks (2 years) of continuous treatment. Participants maintained an average loss of 15.2% of body weight at the two-year mark, demonstrating that semaglutide's effects are durable with ongoing use.

Real-World Results vs. Clinical Trials

It is important to understand that real-world outcomes often differ from clinical trial results. Clinical trials include rigorous participant selection, regular follow-up, and strong lifestyle counseling that may not be replicated in everyday practice. Real-world studies have shown that average weight loss on semaglutide tends to be 10-15%, though individual results vary widely.

Factors That Influence Your Results

  • Starting weight: People with higher starting weights may lose more absolute pounds but a similar percentage of body weight
  • Diet and exercise: Semaglutide works best when combined with a reduced-calorie diet and regular physical activity
  • Dose tolerance: Some individuals cannot tolerate the full 2.4mg dose and may need to stay at a lower dose, which can reduce weight loss
  • Duration of treatment: Most weight loss occurs in the first 60-68 weeks, with weight stabilizing afterward
  • Adherence: Consistent weekly injections and lifestyle modifications are essential for optimal results
  • Diabetes status: People with type 2 diabetes tend to lose less weight on semaglutide
  • Age and metabolism: Individual metabolic factors and age can influence the rate and amount of weight loss

Timeline: When Does Weight Loss Start?

Most people begin to notice weight loss within the first 4-8 weeks of starting semaglutide, although the dose escalation protocol means you are on lower doses during this period. The rate of weight loss typically accelerates once you reach the full 2.4mg dose (usually around week 16-20) and continues steadily for approximately one year before plateauing.

A typical weight loss trajectory looks like this: modest loss during dose escalation, accelerating loss after reaching full dose, peak rate of loss between months 4-8 on the full dose, and gradual plateauing between months 12-18.

Maintaining Weight Loss

One important consideration is that semaglutide weight loss appears to require ongoing treatment to maintain. The STEP 4 trial examined what happens when semaglutide is withdrawn after initial weight loss. Participants who switched from semaglutide to placebo regained approximately two-thirds of their lost weight within one year. This underscores that semaglutide is not a temporary fix but rather a long-term treatment for many individuals.

Realistic Expectations

Setting realistic expectations is essential for a positive treatment experience. While some individuals achieve dramatic weight loss of 20-25% of body weight, others may lose a more modest 8-12%. Both outcomes are clinically significant and associated with improvements in blood pressure, cholesterol, blood sugar, joint pain, sleep quality, and overall quality of life. Weight loss of even 5-10% has been shown to produce meaningful health benefits.

The most important step is to have an honest conversation with your healthcare provider about your goals, medical history, and what you can realistically expect from semaglutide treatment.

semaglutideweight loss resultsWegovySTEP trialsobesityclinical dataGLP-1

Purchase for Research

For laboratory and research purposes only. Not intended for human or animal consumption.

Buy Research Peptides

15% OFF

Use code 50Best at checkout

Stay Updated on Peptide Research

Get the latest peptide research news and updates delivered to your inbox.

Frequently Asked Questions

What does this article cover about semaglutide?

Discover the real-world and clinical trial data on semaglutide weight loss results. Learn how much weight people actually lose, what factors affect outcomes, and what to realistically expect.

Who should read this article on research?

This article is ideal for researchers, students, and anyone interested in learning about semaglutide, weight loss results, wegovy. No prior expertise is required.

Is the information in this article medically reviewed?

All content on 50 Best Peptides is researched and compiled by our editorial team using peer-reviewed scientific sources. Our content is for informational purposes only and is not medical advice.

Where can I find more research on semaglutide?

Browse our full peptide database at 50bestpeptides.com/peptides for detailed profiles, or visit our blog for more in-depth articles on research.

How often is this content updated?

Our editorial team reviews and updates content quarterly to ensure accuracy. This article was last reviewed in July 2026.

Disclaimer: This article is for informational and educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before making any health-related decisions.

The Tribe Manager by Peter Burchardt
The Leadership Companion
The Tribe Manager
Your employees are running stone-age software. Manage with it, you get loyalty and performance. Manage against it, you get quiet quitting and turnover.
Leading People the Way Evolution Intended — by Peter Burchardt
Get It on Amazon →Paperback & Kindle